The next OncoDaily Party lands in Berlin during ESMO 2025, where neon, night beats, and bold ideas collide. Expect high-energy conversations, new connections, and that unmistakable OncoDaily pulse in a city that never stands still.
OncoDaily Party: Berlin
Oct 19, 2025 | TIME
Location: Kastanienallee 82 10435 Berlin
OncoDaily Party 2025: Berlin – Hosting Committee
Hosting Committee
Co-Chairs
Giuseppe Curigliano – President-Elect of the European Society for Medical Oncology (ESMO) and Editor-in-Chief of ESMO Open. He is Director of the Early Drug Development Division and Co-Chair of the Experimental Therapeutics Program at the European Institute of Oncology, Milan, and a member of the Italian National Health Council
Yelena Janjigian – Chief of Gastrointestinal Oncology at the Memorial Sloan Kettering Cancer Center in New York, Professor of Medicine, Weill Cornell Medical College . She is one of the leading voices in advancing treatment for esophagogastric cancers. Her work has helped reshape the landscape of gastrointestinal oncology.
Members
Alberto Puccini: Assistant Professor at Humanitas University and Gastrointestinal Medical Oncologist at IRCCS Humanitas Research Hospital
Amalya Sargsyan: Medical Oncologist, Yeolyan Hematology and Oncology Center, VP, Head of Research and Intelligence unit, OncoDaily
Arturo Loaiza-Bonilla: Co-Founder and Chief Medical Officer at Massive Bio, and Medical Director of Oncology Research at Capital Health
Chandler Park: Oncologist at Norton Cancer Institute and Baptist Health Hardin, Clinical Professor at the University of Louisville School of Medicine, President of the Kentucky Society of Clinical Oncology
Diana Romero: Chief Editor of Nature Reviews Clinical Oncology at Springer Nature, UK
Herbert Loong: Clinical Associate Professor at the Department of Clinical Oncology, Deputy Medical Director, Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Honorary Consultant, Department of Clinical Oncology, Prince of Wales Hospital, Chair-Elect of the ASCO International Committee.
Jenny Seligmann: Consultant Medical Oncologist and Senior Lecturer at the University of Leeds
Jennifer Buell: President and CEO of MiNK Therapeutics, and Chairman of the Board at Agenus
Julien Taieb: Head of the Gastroenterology and Gastrointestinal Oncology Department at the Georges Pompidou European Hospital, Université de Paris, Founder of the AGEO French research group on GI tumours
Kohei Shitara: Director of the Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Japan
Melvin L.K. Chua: Head and Senior Consultant, Department of Head and Neck and Thoracic Cancers, National Cancer Centre Singapore
Paolo Tarantino: Medical Oncologist and researcher at the European Institute of Oncology and clinical research fellow at the Dana-Farber Cancer Institute
Petros Grivas: Clinical Director of the Genitourinary Cancers Program at University of Washington and Seattle Cancer Care Alliance, Associate Professor in the Department of Medicine, Division of Medical Oncology, and Associate Member at the Fred Hutchinson Cancer Research Center
Rachel Riechelmann: Director of the Clinical Oncology Department, AC Camargo Cancer Center, Sao Paulo, Brasil, President of the Brazilian GI Tumors Group (GTG)
Sara Lonardi: Chief of the Oncology 3 Unit of Veneto Institute of Oncology (IOV) – IRCCS, Padova, Italy
Vivek Subbiah: Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, USA
Invitation-only. RSVP required.
For any questions or requests, please contact us at [email protected]